Status:
COMPLETED
Self-Management Using Smartphone Application for Type2 DM in Real siTuation (SMART-DM)
Lead Sponsor:
Inje University
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
21-69 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effectiveness of smartphone application for management of type 2 diabetes mellitus (DM). Type 2 DM is an almost incurable chronic disease and continuous m...
Eligibility Criteria
Inclusion
- Type 2 DM using oral hypoglycemic agent
- 5% \< HbA1c \< 10%
- systolic blood pressure \> 130 mmHg or diastolic blood pressure \> 80 mmHg
- BMI over 23.0
- 20 \< age \< 70
- smartphone user (android OS based)
Exclusion
- Serum fasting glucose \> 250 mg/L or post prandial 2 hour serum glucose \> 350 mg/L
- systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 110 mmHg
- Diabetes mellitus patient using insulin
- severe chronic diabetic complications (diabetic foot ulcer, severe diabetic retinopathy, diabetic nephropathy with severe proteinuria)
- congestive heart failure (NYHA III-IV or left ventricular ejection fraction \< 30%)
- Aspartate aminotransferase (AST) or alanine transaminase (ALT) over 3 times of upper normal limit
- Serum creatinine \> 1.5 mg/dL
- refusal to participate in the study
- drug addiction or alcohol addiction
- major psychiatric illness
- steroid treatment or hormonal treatment with changing the drug or drug dosage in 1 month
- changing dosage of antihypertensive agent, oral hypoglycemic agent or lipid lowering agent in 1 month
- malignant cancer
- pregnancy
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01820871
Start Date
November 1 2012
End Date
October 1 2013
Last Update
November 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haeundae Paik Hospital
Busan, South Korea, 612-030